Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors NCT00499798 Brain and Centr...
Chemotherapeuti...
Infertility
18 Years - 60 Years Wake Forest University Health Sciences View Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors NCT00002647 Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 Years National Cancer Institute (NCI) View Vatalanib in Treating Patients With Recurrent or Progressive Meningioma NCT00348790 Brain and Centr...
Sarcoma
vatalanib
18 Years - Northwestern University View Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 NCT01082926 Anaplastic Astr...
Anaplastic Epen...
Anaplastic Meni...
Anaplastic Olig...
Brain Stem Glio...
Ependymoblastom...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Grade III Menin...
Meningeal Heman...
Mixed Glioma
Pineal Gland As...
Brain Tumor
therapeutic all...
aldesleukin
laboratory biom...
positron emissi...
18 Years - 70 Years City of Hope Medical Center View Study of Tissue Samples From Patients With Glioma or Other Brain Tumors NCT00967200 Central Nervous...
laboratory biom...
pharmacogenomic...
18 Years - 120 Years University Hospital, Montpellier View Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma NCT00895622 Brain and Centr...
54 Gy radiother...
60 Gy radiother...
18 Years - Radiation Therapy Oncology Group View Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma NCT00904735 Brain and Centr...
hydroxyurea
imatinib mesyla...
18 Years - 75 Years National Cancer Institute (NCI) View Vatalanib in Treating Patients With Recurrent or Progressive Meningioma NCT00348790 Brain and Centr...
Sarcoma
vatalanib
18 Years - Northwestern University View Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma NCT00904735 Brain and Centr...
hydroxyurea
imatinib mesyla...
18 Years - 75 Years National Cancer Institute (NCI) View Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas NCT01125046 Acoustic Schwan...
Adult Anaplasti...
Adult Ependymom...
Adult Grade I M...
Adult Grade II ...
Adult Meningeal...
Adult Papillary...
Neurofibromatos...
Neurofibromatos...
Recurrent Adult...
bevacizumab
18 Years - Northwestern University View Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers NCT00376818 Brain and Centr...
Psychosocial Ef...
exercise interv...
educational int...
physiologic tes...
management of t...
mind-body inter...
Measurement of ...
18 Years - Case Comprehensive Cancer Center View Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders NCT00255671 Brain and Centr...
Metastatic Canc...
Radiation Toxic...
Questionnaire
18 Years - Case Comprehensive Cancer Center View Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas NCT01125046 Acoustic Schwan...
Adult Anaplasti...
Adult Ependymom...
Adult Grade I M...
Adult Grade II ...
Adult Meningeal...
Adult Papillary...
Neurofibromatos...
Neurofibromatos...
Recurrent Adult...
bevacizumab
18 Years - Northwestern University View Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors NCT00629889 Brain and Centr...
Seizure
levetiracetam
pregabalin
18 Years - Centre Hospitalier Universitaire Vaudois View Yoga Therapy in Treating Patients With Malignant Brain Tumors NCT01234805 Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Supratent...
Recurrent Adult...
yoga therapy
questionnaire a...
quality-of-life...
18 Years - Wake Forest University Health Sciences View Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment NCT00544284 Brain and Centr...
Lymphoma
Metastatic Canc...
Unspecified Adu...
bortezomib
temozolomide
pharmacological...
18 Years - City of Hope Medical Center View Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors NCT02194452 Acoustic Schwan...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Papillary...
Adult Pilocytic...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Subependy...
Adult Supratent...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Supra...
Meningeal Melan...
Newly Diagnosed...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
gallium Ga 68-e...
positron emissi...
computed tomogr...
laboratory biom...
6 Months - 29 Years University of Iowa View Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer NCT00492089 Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors NCT00629889 Brain and Centr...
Seizure
levetiracetam
pregabalin
18 Years - Centre Hospitalier Universitaire Vaudois View Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma NCT00354913 Glioblastoma
Gliosarcoma
hydroxyurea
imatinib mesyla...
18 Years - Duke University View Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas NCT01125046 Acoustic Schwan...
Adult Anaplasti...
Adult Ependymom...
Adult Grade I M...
Adult Grade II ...
Adult Meningeal...
Adult Papillary...
Neurofibromatos...
Neurofibromatos...
Recurrent Adult...
bevacizumab
18 Years - Northwestern University View Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma NCT00895622 Brain and Centr...
54 Gy radiother...
60 Gy radiother...
18 Years - Radiation Therapy Oncology Group View Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer NCT00492089 Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI) View